93 155 (Topiramate 25 mg)

Pill imprint 93 155 has been identified as Topiramate 25 mg.

Topiramate is used in the treatment of obesity; bipolar disorder; migraine prevention; fibromyalgia; trigeminal neuralgia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 155

Topiramate 25 mg 93 155
Topiramate 25 mg 93 155
Topiramate 25 mg 93 155
Topiramate
Imprint:
93
155
Strength:
25 mg
Color:
White
Size:
8.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-0155
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
hypromelloses
polydextrose

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)